amiridine and Hearing-Loss--Sensorineural

The objective of the present study was to evaluate the efficiency of meatotympanal blockade by neuromedin (ipidacrine) included in the combined treatment of sensorineraul loss of hearing. This therapy was given to 95 patients with sensorineural hearing loss of vascular origin who reported strong tympanophony. Results of audiological examination and ultrasound dopplerography as well as the patients' subjective feeling provided data for the conclusion that medicamentous therapy of sensorineural loss of hearing produces the best effect if combined with meatotympanal blockade by 1 ml (15 mg) of a 1% neuromedine solution during 10 days.

Topics: Adolescent; Adult; Aminoquinolines; Cholinesterase Inhibitors; Combined Modality Therapy; Female; Hearing Loss, Sensorineural; Humans; Male; Middle Aged; Nerve Block; Treatment Outcome; Young Adult